ICON plc (ICLR)
173.54
+1.09
(+0.63%)
USD |
NASDAQ |
Sep 16, 11:28
ICON Price to Book Value : 1.428 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 1.419 |
| September 14, 2026 | 1.390 |
| September 11, 2026 | 1.393 |
| September 10, 2026 | 1.363 |
| September 09, 2026 | 1.312 |
| September 08, 2026 | 1.303 |
| September 04, 2026 | 1.356 |
| September 03, 2026 | 1.346 |
| September 02, 2026 | 1.315 |
| September 01, 2026 | 1.328 |
| August 31, 2026 | 1.357 |
| August 28, 2026 | 1.399 |
| August 27, 2026 | 1.396 |
| August 26, 2026 | 1.390 |
| August 25, 2026 | 1.390 |
| August 24, 2026 | 1.427 |
| August 21, 2026 | 1.417 |
| August 20, 2026 | 1.434 |
| August 19, 2026 | 1.419 |
| August 18, 2026 | 1.374 |
| August 17, 2026 | 1.394 |
| August 14, 2026 | 1.342 |
| August 13, 2026 | 1.378 |
| August 12, 2026 | 1.375 |
| August 11, 2026 | 1.362 |
| Date | Value |
|---|---|
| August 10, 2026 | 1.366 |
| August 07, 2026 | 1.353 |
| August 06, 2026 | 1.326 |
| August 05, 2026 | 1.345 |
| August 04, 2026 | 1.290 |
| August 03, 2026 | 1.303 |
| July 31, 2026 | 1.346 |
| July 30, 2026 | 1.362 |
| July 29, 2026 | 1.466 |
| July 28, 2026 | 1.483 |
| July 27, 2026 | 1.389 |
| July 24, 2026 | 1.364 |
| July 23, 2026 | 1.401 |
| July 22, 2026 | 1.376 |
| July 21, 2026 | 1.371 |
| July 20, 2026 | 1.367 |
| July 17, 2026 | 1.399 |
| July 16, 2026 | 1.399 |
| July 15, 2026 | 1.416 |
| July 14, 2026 | 1.382 |
| July 13, 2026 | 1.366 |
| July 10, 2026 | 1.380 |
| July 09, 2026 | 1.388 |
| July 08, 2026 | 1.361 |
| July 07, 2026 | 1.388 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| IQVIA Holdings, Inc. | 7.228 |
| Medpace Holdings, Inc. | 39.72 |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | 17.55 |
| Avantor, Inc. | 1.878 |
Price to Book Value Related Metrics
| PE Ratio | 315.01 |
| PS Ratio | 1.618 |
| Price to Free Cash Flow | 15.01 |
| Price | 173.54 |
| Earnings Yield | 0.32% |
| Market Cap | 13.39B |
| Operating PE Ratio | 15.95 |
| Normalized PE Ratio | 33.49 |